Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor system update rather than any change to the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, representing a small platform update to the page. This change does not modify study content, eligibility, or results.
    Difference
    0.0%
    Check dated 2026-04-30T18:36:15.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:37:15.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and a link to the Genetic and Rare Diseases Information Center in the page's Resources section.
    Difference
    0.1%
    Check dated 2026-04-02T01:32:49.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:42:54.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no changes to study content or results are visible.
    Difference
    0.0%
    Check dated 2026-03-11T16:46:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.